SYK
Price
$357.52
Change
-$1.52 (-0.42%)
Updated
Mar 28, 6:59 PM EST
25 days until earnings call
XRAY
Price
$33.19
Change
-$0.12 (-0.36%)
Updated
Mar 28, 6:59 PM EST
39 days until earnings call
Ad is loading...

Compare trend and price SYK vs XRAY

Header iconSYK vs XRAY Comparison
Open Charts SYK vs XRAYBanner chart's image
Stryker
Price$357.52
Change-$1.52 (-0.42%)
Volume$171.66K
CapitalizationN/A
DENTSPLY SIRONA
Price$33.19
Change-$0.12 (-0.36%)
Volume$1.42M
CapitalizationN/A
View a ticker or compare two or three
SYK vs XRAY Comparison Chart

Loading...

SYKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XRAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
SYK vs. XRAY commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYK is a StrongBuy and XRAY is a StrongSell.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (SYK: $357.87 vs. XRAY: $33.18)
Brand notoriety: SYK and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SYK: 85% vs. XRAY: 81%
Market capitalization -- SYK: $136.16B vs. XRAY: $6.88B
SYK [@Medical Specialties] is valued at $136.16B. XRAY’s [@Medical Specialties] market capitalization is $6.88B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYK’s FA Score shows that 3 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • SYK’s FA Score: 3 green, 2 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, SYK is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYK’s TA Score shows that 4 TA indicator(s) are bullish while XRAY’s TA Score has 4 bullish TA indicator(s).

  • SYK’s TA Score: 4 bullish, 3 bearish.
  • XRAY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SYK is a better buy in the short-term than XRAY.

Price Growth

SYK (@Medical Specialties) experienced а +1.46% price change this week, while XRAY (@Medical Specialties) price change was -0.32% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.84%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was +4.27%.

Reported Earning Dates

SYK is expected to report earnings on Apr 23, 2024.

XRAY is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Medical Specialties (+0.84% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for SYK with price predictions.
OPEN
A.I.dvisor published
a Summary for XRAY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SYK($136B) has a higher market cap than XRAY($6.88B). SYK has higher P/E ratio than XRAY: SYK (43.38) vs XRAY (19.23). SYK YTD gains are higher at: 19.779 vs. XRAY (-6.310). SYK has higher annual earnings (EBITDA): 4.93B vs. XRAY (249M). XRAY has less debt than SYK: XRAY (2.12B) vs SYK (13B). SYK has higher revenues than XRAY: SYK (20.5B) vs XRAY (3.97B).
SYKXRAYSYK / XRAY
Capitalization136B6.88B1,977%
EBITDA4.93B249M1,982%
Gain YTD19.779-6.310-313%
P/E Ratio43.3819.23226%
Revenue20.5B3.97B517%
Total CashN/A1.27B-
Total Debt13B2.12B612%
FUNDAMENTALS RATINGS
SYK vs XRAY: Fundamental Ratings
SYK
XRAY
OUTLOOK RATING
1..100
589
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
13100
SMR RATING
1..100
5291
PRICE GROWTH RATING
1..100
2160
P/E GROWTH RATING
1..100
6687
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (8) in the Medical Specialties industry is in the same range as SYK (20). This means that XRAY’s stock grew similarly to SYK’s over the last 12 months.

SYK's Profit vs Risk Rating (13) in the Medical Specialties industry is significantly better than the same rating for XRAY (100). This means that SYK’s stock grew significantly faster than XRAY’s over the last 12 months.

SYK's SMR Rating (52) in the Medical Specialties industry is somewhat better than the same rating for XRAY (91). This means that SYK’s stock grew somewhat faster than XRAY’s over the last 12 months.

SYK's Price Growth Rating (21) in the Medical Specialties industry is somewhat better than the same rating for XRAY (60). This means that SYK’s stock grew somewhat faster than XRAY’s over the last 12 months.

SYK's P/E Growth Rating (66) in the Medical Specialties industry is in the same range as XRAY (87). This means that SYK’s stock grew similarly to XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SYKXRAY
RSI
ODDS (%)
Bearish Trend 1 day ago
30%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
63%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 10 days ago
58%
Bullish Trend 8 days ago
60%
Declines
ODDS (%)
Bearish Trend 3 days ago
49%
Bearish Trend 14 days ago
67%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 3 days ago
66%
View a ticker or compare two or three
Ad is loading...
SYKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XRAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMD9.610.08
+0.84%
Western Asset Emerging Markets Debt Fund
BFIT21.39N/A
N/A
Global X Health & Wellness ETF
SCHI44.49-0.07
-0.16%
Schwab 5-10 Year Corp Bd ETF
OVT22.28-0.05
-0.24%
Overlay Shares Short Term Bond ETF
SCO16.02-0.27
-1.66%
ProShares UltraShort Bloomberg Crude Oil

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been closely correlated with BSX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
-0.23%
BSX - SYK
67%
Closely correlated
-0.19%
RVTY - SYK
60%
Loosely correlated
-0.39%
ZBH - SYK
60%
Loosely correlated
-0.48%
ISRG - SYK
56%
Loosely correlated
-0.25%
ABT - SYK
51%
Loosely correlated
+0.16%
More